Annual report pursuant to Section 13 and 15(d)

Condensed Consolidating Financial Statements (Details 4)

v2.4.0.6
Condensed Consolidating Financial Statements (Details 4) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Sep. 30, 2010
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Sources (uses) of cash and cash equivalents        
Net cash provided by (used in) operating activities   $ (22,827) $ 80,730 $ 113,968
Investing activities:        
Capital expenditures   (46,174) (49,314) (34,989)
Investment in NEC TOKIN   (50,917)    
Change in restricted cash   (15,284)    
Acquisitions, net of cash received     (42,613)  
Proceeds from sales of assets 3,400 398 74 5,425
Net cash used in investing activities   (111,977) (91,853) (29,564)
Financing activities:        
Proceeds from issuance of debt   39,825 116,050 227,525
Deferred acquisition payments   (16,900)    
Payment of long-term debt   (1,909) (40,581) (230,413)
Net (payments) borrowings under other credit facilities     (3,154) (2,479)
Debt issuance costs   (275) (2,313) (7,853)
Debt extinguishment costs       (207)
Proceeds from exercise of stock options   111 290 89
Net cash provided by (used in) financing activities   20,852 70,292 (13,338)
Net (decrease) increase in cash and cash equivalents   (113,952) 59,169 71,066
Effect of foreign currency fluctuations on cash   (591) (699) 1,786
Cash and cash equivalents at beginning of fiscal year   210,521 152,051 79,199
Cash and cash equivalents at end of fiscal year   95,978 210,521 152,051
Parent
       
Sources (uses) of cash and cash equivalents        
Net cash provided by (used in) operating activities   (14,492) (71,930) (13,967)
Financing activities:        
Proceeds from issuance of debt   39,825 116,050 226,976
Deferred acquisition payments   (15,900)    
Payment of long-term debt     (40,581) (210,604)
Debt issuance costs   (275) (2,313) (7,472)
Debt extinguishment costs       (207)
Proceeds from exercise of stock options   111 290 89
Net cash provided by (used in) financing activities   23,761 73,446 8,782
Net (decrease) increase in cash and cash equivalents   9,269 1,516 (5,185)
Cash and cash equivalents at beginning of fiscal year   7,933 6,417 11,602
Cash and cash equivalents at end of fiscal year   17,202 7,933 6,417
Guarantor Subsidiaries
       
Sources (uses) of cash and cash equivalents        
Net cash provided by (used in) operating activities   (43,099) 124,591 90,445
Investing activities:        
Capital expenditures   (15,841) (23,099) (15,842)
Investment in NEC TOKIN   (50,917)    
Change in restricted cash   (15,284)    
Acquisitions, net of cash received     (42,613)  
Proceeds from sales of assets       5,425
Net cash used in investing activities   (82,042) (65,712) (10,417)
Financing activities:        
Deferred acquisition payments   (1,000)    
Payment of long-term debt   (8)   (15,000)
Debt issuance costs       (381)
Net cash provided by (used in) financing activities   (1,008)   (15,381)
Net (decrease) increase in cash and cash equivalents   (126,149) 58,879 64,647
Effect of foreign currency fluctuations on cash       (28)
Cash and cash equivalents at beginning of fiscal year   178,205 119,326 54,707
Cash and cash equivalents at end of fiscal year   52,056 178,205 119,326
Non-Guarantor Subsidiaries
       
Sources (uses) of cash and cash equivalents        
Net cash provided by (used in) operating activities   34,764 28,069 37,490
Investing activities:        
Capital expenditures   (30,333) (26,215) (19,147)
Proceeds from sales of assets   398 74  
Net cash used in investing activities   (29,935) (26,141) (19,147)
Financing activities:        
Proceeds from issuance of debt       549
Payment of long-term debt   (1,901)   (4,809)
Net (payments) borrowings under other credit facilities     (3,154) (2,479)
Net cash provided by (used in) financing activities   (1,901) (3,154) (6,739)
Net (decrease) increase in cash and cash equivalents   2,928 (1,226) 11,604
Effect of foreign currency fluctuations on cash   (591) (699) 1,814
Cash and cash equivalents at beginning of fiscal year   24,383 26,308 12,890
Cash and cash equivalents at end of fiscal year   $ 26,720 $ 24,383 $ 26,308